Safer Aging With Diabetes Monitoring
Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Use in High-Risk Older Adults With Type 2 Diabetes
Kaiser Permanente
360 participants
May 1, 2024
INTERVENTIONAL
Conditions
Summary
Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.
Eligibility
Inclusion Criteria6
- Age 75 years and older
- Diagnosis of Type 2 Diabetes
- Current treatment with insulin
- Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization)
- Able to communicate in English
- Able to access email and the Internet
Exclusion Criteria8
- On renal dialysis
- Dementia
- Pacemaker or Automatic Implantable Cardioverter Defibrillator
- Using insulin pump
- Severe Mental Illness
- Severe Visual Impairment
- In Hospice
- Current or recent CGM use
Interventions
Participants continue to receive usual care (Control Arm)
Participants enroll in 3 educational group sessions and receive CGMs
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06296485